Cite
HARVARD Citation
Maynard, J. et al. (2022). P2X4 purinergic receptors offer a therapeutic target for aggressive prostate cancer. Journal of pathology. 256 (2), pp. 149-163. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Maynard, J. et al. (2022). P2X4 purinergic receptors offer a therapeutic target for aggressive prostate cancer. Journal of pathology. 256 (2), pp. 149-163. [Online].